There is a significant gap in the studies of the role of the fibrinolytic system in breast cancer, considering several laboratory parameters such as t-PA, u-PA, PAI-1, and especially the PAI-1/t-PA and PAI-1/u-PA complexes. The gene discussed is PLAU; the disease is breast carcinoma.